Associations between classical cardiovascular risk factors and coronary artery disease in two countries at contrasting risk for myocardial infarction:: the PRIME Study

被引:18
作者
Graille, V
Ferrières, J
Evans, A
Amouyel, P
Arveiler, D
Luc, G
Ducimetière, P
机构
[1] Fac Med Toulouse, INSERM U518, Dept Epidemiol, F-31073 Toulouse, France
[2] Queens Univ Belfast, Dept Epidemiol & Publ Hlth, Belfast, Antrim, North Ireland
[3] INSERM U508, Lille, France
[4] Fac Med Strasbourg, Strasbourg, France
[5] SERLIA, INSERM U325, Lille, France
[6] INSERM U258, Paris, France
关键词
apolipoproteins; coronary artery disease; epidemiological methods; lipoproteins; risk factors;
D O I
10.1016/S0167-5273(00)00283-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: In two countries with contrasting risk for coronary artery disease (CAD)-Northern Ireland and France-a case-control study was performed on baseline data within a cohort study to compare the strength of the associations between CAD prevalence and classical risk factors. Method and results: A sample of 9561 men, aged 50-60 years, was studied: 382 had had myocardial infarction or angina, and 9179 were controls. In both countries, variables associated with CAD were age, body mass index, hypertension, diabetes, family history of myocardial infarction (MI), tobacco consumption, triglycerides, HDL-cholesterol, apolipoprotein A-I and B levels. Logistic regression analyses were conducted using standardized odds ratios. The strength of the associations with CAD was rather similar in the two countries (Northem Ireland versus France) for age [1.26 (1.10-1.45) vs. 1.41 (1.17-1.69)], family history of MI [1.50 (1.04-2.15) vs. 1.83 (0.99-3.37)], hypertension [1.49 (1.13-1.97) vs. 1.67 (1.14-2.44)], diabetes [5.42 (2.53-11.60) vs. 2.24 (1.06-4.73)], tobacco consumption [1.43 (1.27-1.60) vs. 1.39 (1.22-1.58)], HDL-cholesterol [0.80 (0.68-0.94) vs. 0.86 (0.70-1.06)] and triglyceride levels [1.17 (1.01-1.36) vs. 1.10 (0.91-1.32)]. Discrepancies concerned lipoprotein(a) [1.22 (1.06-1.40) vs. 0.96 (0.81-1.15), P<0.01], with stronger associations in Northern Ireland than in France. Conclusion: It is concluded that the higher prevalence of CAD in Northern Ireland cannot be explained by major differences in the susceptibility to classical risk factors; the difference in risk of CAD appears mainly related in Northern Ireland to other risk factors including a worse lipid profile and genetic/environmental interactions. Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:191 / 198
页数:8
相关论文
共 41 条
[21]   PREDICTIVE VALUE OF TISSUE-PLASMINOGEN ACTIVATOR MASS CONCENTRATION ON LONG-TERM MORTALITY IN PATIENTS WITH CORONARY-ARTERY DISEASE - A 7-YEAR FOLLOW-UP [J].
JANSSON, JH ;
OLOFSSON, BO ;
NILSSON, TK .
CIRCULATION, 1993, 88 (05) :2030-2034
[22]   Parental history of premature coronary heart disease: An independent risk factor of myocardial infarction [J].
Jousilahti, P ;
Puska, P ;
Vartiainen, E ;
Pekkanen, J ;
Tuomilehto, J .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1996, 49 (05) :497-503
[23]   Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris [J].
JuhanVague, I ;
Pyke, SDM ;
Alessi, MC ;
Jespersen, J ;
Haverkate, F ;
Thompson, SG .
CIRCULATION, 1996, 94 (09) :2057-2063
[24]   CDNA SEQUENCE OF HUMAN APOLIPOPROTEIN(A) IS HOMOLOGOUS TO PLASMINOGEN [J].
MCLEAN, JW ;
TOMLINSON, JE ;
KUANG, WJ ;
EATON, DL ;
CHEN, EY ;
FLESS, GM ;
SCANU, AM ;
LAWN, RM .
NATURE, 1987, 330 (6144) :132-137
[25]   CORONARY MORTALITY AND ITS PREDICTION IN SAMPLES OF US AND ITALIAN RAILROAD EMPLOYEES IN 25 YEARS WITHIN THE 7 COUNTRIES STUDY OF CARDIOVASCULAR-DISEASES [J].
MENOTTI, A ;
SECCARECCIA, F ;
BLACKBURN, H ;
KEYS, A .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1995, 24 (03) :515-521
[26]  
MENOTTI A, 1993, EUR J EPIDEMIOL, V9, P527, DOI 10.1007/BF00209531
[27]   IN DEFENSE OF STANDARDIZED REGRESSION-COEFFICIENTS [J].
NEWMAN, TB ;
BROWNER, WS .
EPIDEMIOLOGY, 1991, 2 (05) :383-386
[28]   UTILIZATION OF DRUG SALES DATA FOR THE EPIDEMIOLOGY OF CHRONIC DISEASES - THE EXAMPLE OF DIABETES [J].
PAPOZ, L .
EPIDEMIOLOGY, 1993, 4 (05) :421-427
[29]   PATTERN OF TREATMENT AMONG DIABETIC-PATIENTS IN FRANCE [J].
PAPOZ, L ;
VAUZELLE, F ;
VEXIAU, P ;
CATHELINEAU, G .
DIABETES CARE, 1988, 11 (07) :586-591
[30]   A CASE CONTROL STUDY OF LIPOPROTEIN PARTICLES IN 2 POPULATIONS AT CONTRASTING RISK FOR CORONARY HEART-DISEASE - THE ECTIM STUDY [J].
PARRA, HJ ;
ARVEILER, D ;
EVANS, AE ;
CAMBOU, JP ;
AMOUYEL, P ;
BINGHAM, A ;
MCMASTER, D ;
SCHAFFER, P ;
DOUSTEBLAZY, P ;
LUC, G ;
RICHARD, JL ;
DUCIMETIERE, P ;
FRUCHART, JC ;
CAMBIEN, F .
ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (06) :701-707